EP2773349A1 - USE OF (N- [2, 4 -BIS (1, 1 -DIMETHYLETHYL) - 5 - HYDROXYPHENYL]- 1, 4 - DIHYDRO - 4 - OXOQUINOLINE - 3 - CARBOXAMIDE) FOR TREATING CFTR MEDIATED DISEASES